Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Quince Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- −3 vs. Q1 2024
- Shares held
- 6.25M
- −1.02M (−14.1%) vs. Q1 2024
- Total value
- $4.68M
- −$3.03M (−39.3%) vs. Q1 2024
- New holders
- 2
- 11 more added
- Sold out
- 5
- 11 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 1,500,000 | $1.13M | 0.11% | −1,447,652−49.1% | Reduced |
| Vanguard Group Inc | 1,214,621 | $911.0K | 0.00% | +83,091+7.3% | Added |
| EPIQ Capital Group, LLC | 852,361 | $639.3K | 0.23% | +6,588+0.8% | Added |
| Renaissance Technologies LLC | 483,902 | $362.9K | 0.00% | −36,198−7.0% | Reduced |
| BlackRock Inc. | 354,788 | $266.1K | 0.00% | +22,702+6.8% | Added |
| HighTower Advisors, LLC | 341,570 | $251.0K | 0.00% | +341,570 | New |
| Geode Capital Management, LLC | 272,955 | $204.8K | 0.00% | +6,059+2.3% | Added |
| Alphabet Inc. | 189,122 | $141.8K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 157,972 | $118.5K | 0.00% | −11,929−7.0% | Reduced |
| Bridgeway Capital Management, LLC | 138,495 | $103.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 99,844 | $74.9K | 0.00% | +73,388+277.4% | Added |
| Susquehanna International Group, LLP | 98,603 | $74.0K | 0.00% | +1,821+1.9% | Added |
| Two Sigma Advisers, LP | 93,600 | $70.2K | 0.00% | −3,500−3.6% | Reduced |
| ADAR1 Capital Management, LLC | 92,958 | $69.7K | 0.01% | +66,129+246.5% | Added |
| Mariner, LLC | 74,074 | $55.6K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 56,611 | $42.5K | 0.00% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 53,312 | $40.0K | 0.01% | −430−0.8% | Reduced |
| Millennium Management LLC | 36,567 | $27.4K | 0.00% | −17,112−31.9% | Reduced |
| Northern Trust Corp | 34,023 | $25.5K | 0.00% | −56−0.2% | Reduced |
| Kestra Advisory Services, LLC | 15,359 | $11.5K | 0.00% | +2,412+18.6% | Added |
| XTX Topco Ltd | 14,077 | $10.6K | 0.00% | +14,077 | New |
| Nixon Peabody Trust Co | 11,126 | $8.35K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,013 | $8.26K | 0.00% | 00.0% | Unchanged |
| Brinker Capital Investments, LLC | 10,136 | $7.60K | 0.00% | 00.0% | Unchanged |
| Orion Portfolio Solutions, LLC | 10,136 | $7.60K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,618 | $7.21K | 0.00% | +2,340+32.2% | Added |
| Morgan Stanley | 8,522 | $6.39K | 0.00% | +122+1.5% | Added |
| Citigroup Inc | 5,165 | $3.87K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,600 | $1.20K | 0.00% | −8−0.5% | Reduced |
| Simplex Trading, LLC | 2,101 | $1.00K | 0.00% | −2,606−55.4% | Reduced |
| UBS Group AG | 480 | $360 | 0.00% | −25−5.0% | Reduced |
| JPMorgan Chase & Co | 469 | $352 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 431 | $323 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 394 | $295 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $255 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 310 | $233 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $221 | 0.00% | −16−5.1% | Reduced |
| Advisor Group Holdings, Inc. | 277 | $207 | 0.00% | 00.0% | Unchanged |
| Financial Avengers, Inc. | 100 | $75 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 100 | $75 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 75 | $56 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 24 | $18 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 279 | $0 | 0.00% | +58+26.2% | Added |
| Scharf Investments, LLC | 0 | $0 | 0.00% | −91,061−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −22,523−100.0% | Sold out |
| Westmount Partners, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −268−100.0% | Sold out |